Fortress Biotech (FBIO) Competitors

Ironwood Pharmaceuticals (NASDAQ:IRWD) and Fortress Biotech (NASDAQ:FBIO) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

Which has preferable earnings and valuation, IRWD or FBIO?

Ironwood Pharmaceuticals has higher revenue and earnings than Fortress Biotech. Ironwood Pharmaceuticals is trading at a lower price-to-earnings ratio than Fortress Biotech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ironwood Pharmaceuticals	$308.52M	0.54	$880K	-$0.05	-20.60
Fortress Biotech	$57.67M	1.09	-$46M	-$1.05	-2.02

Do analysts prefer IRWD or FBIO?

Ironwood Pharmaceuticals presently has a consensus target price of $4.94, indicating a potential upside of 379.61%. Fortress Biotech has a consensus target price of $21.00, indicating a potential upside of 890.57%. Given Fortress Biotech's stronger consensus rating and higher possible upside, analysts clearly believe Fortress Biotech is more favorable than Ironwood Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ironwood Pharmaceuticals	0 Sell rating(s)	6 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.14
Fortress Biotech	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Do insiders & institutionals have more ownership in IRWD or FBIO?

96.5% of Fortress Biotech shares are held by institutional investors. 12.7% of Ironwood Pharmaceuticals shares are held by company insiders. Comparatively, 27.9% of Fortress Biotech shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Does the media favor IRWD or FBIO?

In the previous week, Ironwood Pharmaceuticals had 6 more articles in the media than Fortress Biotech. MarketBeat recorded 11 mentions for Ironwood Pharmaceuticals and 5 mentions for Fortress Biotech. Ironwood Pharmaceuticals' average media sentiment score of -0.03 beat Fortress Biotech's score of -0.40 indicating that Ironwood Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ironwood Pharmaceuticals	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
Fortress Biotech	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has more risk and volatility, IRWD or FBIO?

Ironwood Pharmaceuticals has a beta of 0.33, suggesting that its stock price is 67% less volatile than the S&P 500. Comparatively, Fortress Biotech has a beta of 1.76, suggesting that its stock price is 76% more volatile than the S&P 500.

Is IRWD or FBIO more profitable?

Ironwood Pharmaceuticals has a net margin of -2.25% compared to Fortress Biotech's net margin of -24.84%. Ironwood Pharmaceuticals' return on equity of -2.46% beat Fortress Biotech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ironwood Pharmaceuticals	-2.25%	-2.46%	2.19%
Fortress Biotech	-24.84%	-693.95%	-27.94%

Summary

Ironwood Pharmaceuticals and Fortress Biotech tied by winning 8 of the 16 factors compared between the two stocks.